Foetal nutrition, foetal growth restriction and health later in life

T Henriksen1

  • 1Institute for Nutrition Research and Department of Obstetrics and Gynecology, University of Oslo, Norway.

Insights

Small for gestational age (SGA) and intrauterine growth retardation (IUGR) are distinct concepts. Current methods for identifying fetal growth issues are too crude, necessitating advanced biophysical and biochemical measures for better risk assessment.

Area of Science:

  • Perinatal Medicine
  • Fetal Development
  • Neonatal Health

Background:

  • Retarded intrauterine growth is associated with increased risks of perinatal mortality, morbidity, sudden infant death, and long-term health issues.
  • Current clinical and epidemiological studies often rely on crude neonatal size parameters like weight and ponderal index to assess fetal growth.
  • Existing parameters are insufficient for accurately identifying fetuses at risk for short- and long-term health problems.

Purpose of the Study:

  • To critically discuss the concepts of growth retardation used in clinical and epidemiological studies.
  • To differentiate between small for gestational age (SGA) and intrauterine growth retardation (IUGR).
  • To highlight the limitations of current assessment methods and propose improvements for identifying at-risk fetuses.

Main Methods:

  • Review and conceptual discussion of existing literature on intrauterine growth retardation.
  • Analysis of the limitations of commonly used neonatal size parameters (e.g., weight, ponderal index).
  • Exploration of the potential of advanced biophysical and biochemical measurements for improved fetal assessment.

Main Results:

  • Small for gestational age (SGA) is a size parameter that does not always reflect restricted fetal growth and has limited value.
  • Intrauterine growth retardation (IUGR), defined as retarded fetal growth rate, may still be too crude a criterion for selecting fetuses with health risks.
  • Different causes of IUGR (e.g., maternal nutrition vs. placental function) can have varying effects on fetal outcomes.

Conclusions:

  • There is a need to move beyond crude size parameters for assessing fetal growth and associated health risks.
  • Advanced biophysical and biochemical measurements are crucial for better selection of fetuses and infants affected by IUGR.
  • Future research should focus on the biology of fetal development and the intrauterine environment to better understand long-term health risks.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...